Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Using simulated scenarios to train front-line staff in the COVID-19 response

Tucked away in an unassuming annexe at the back of the John Radcliffe Hospital you will find a powerhouse at the centre of training NHS staff on the COVID-19 front line. This is OxSTaR (Oxford Simulation, Teaching and Research), the University of Oxford’s state-of-the-art medical simulation, teaching and research facility. This unit, led by Dr Helen Higham, is part of the Nuffield Division of Anaesthetics in the Nuffield Department of Clinical Neurosciences. It embodies the incredible impact that can be achieved when robust research meets clinical practice — and never more so than in a global crisis such as the one in which we now find ourselves.

For 12 years, OxSTaR has been running simulated scenarios — complete with highly realistic functioning models of patients known as manikins — to understand and improve how healthcare professionals work together and interact with their environment and equipment. They have used the insights gained to provide training across Oxford University Hospitals (OUH). Recent weeks have seen them rise to the unique challenge of supporting front-line clinical staff during a pandemic. Helen is full of praise for everyone involved in this effort, particularly the members of her core team: Rosie Warren, Alan Inglis, Russ Sinclair, Charlie McDermott, Wendy Washbourn and Paul Hambidge. This outstanding example of the University and OUH working in partnership has also hinged on the enthusiastic engagement of OxSTaR’s faculty (largely anaesthetics and intensive care consultants and trainees), and support from OUH Infection Prevention and Control team, Corporate Education, the Chief Medical and Nursing Officers and Oxford Medical Imaging.

Read more on the University of Oxford Medium channel

Similar stories

Communication at the crossroads of the immune system

In his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.

Showcase success for Science Together research

A local collaboration teaming researchers from the University of Oxford and Oxford Brookes University with the Urban Music Foundation finished on a high note with an immersive sound and art installation at Oxford’s Old Fire Station.

Oxford spinout trials revolutionary bioelectronic implant to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their “smart” bioelectronic implants.

COVID-19 is a leading cause of death in children and young people in the US

A new study led by researchers at the University of Oxford’s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.

Three or more concussions linked with worse brain function in later life

Experiencing three or more concussions is linked with worsened brain function in later life, according to new research.

New blood test could save lives of heart attack victims

Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test – costing just £10 – could ensure patients receive timely life-saving treatment.